Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMIG4.L Regulatory News (MIG4)

  • There is currently no data for MIG4

Interim Management Statement

14 Nov 2022 16:00

RNS Number : 3503G
Mobeus Income & Growth 4 VCT PLC
14 November 2022
 

 

Mobeus Income & Growth 4 VCT plc

("the Company")

LEI: 213800IFNJ65R8AQW943

 

INTERIM MANAGEMENT STATEMENT

For the quarter ended 30 September 2022

 

Mobeus Income & Growth 4 VCT plc presents an Interim Management Statement for the quarter ended 30 September 2022. The statement also includes relevant financial information between the end of the period and the date of this statement.

 

NET ASSET VALUE AND TOTAL RETURN PER SHARE

At 30 September 2022

(unaudited)

At 30 June 2022

(unaudited)

Net assets attributable to shareholders

£78.93 million

£86.13 million

Shares in issue

91,244,441

90,990,361

Net asset value (NAV) per share

86.50 pence

94.66 pence

Cumulative dividends paid

147.20 pence

143.20 pence

Cumulative Total return (net asset value basis) per share since inception

233.70 pence

237.86 pence

 

The NAV per share has decreased by 8.16 pence in the quarter (a decrease of 8.6% from the opening NAV per share). This decrease arises both from the 4.00 pence per share dividend paid in July 2022 as well as a fall in unrealised valuations. On a total return basis, after adding back the dividend of 4.00 pence per share, the decrease is 4.4%.

 

OFFER FOR SUBSCRIPTION

 

On 17 October 2022, the Company took part in a Joint Offer for Subscription ("Offer") alongside the other Mobeus VCTs seeking to raise an initial amount of £11 million for the Company with an over-allotment facility of £5 million available. Following strong demand for the Offer, the Directors approved the utilisation of the over-allotment facility later on 17 October 2022. As stated in the Prospectus, the first allotment under the Offer in relation to applications accepted for the initial amount is expected on or around 16 November 2022. Accepted applications by the Company for the over-allotment facility will be allotted in January 2023.

 

DIVIDENDS PAID/DECLARED IN THE PERIOD

 

On 8 July 2022, an interim dividend of 4.00 pence per share in respect of the year ending 31 December 2022 was paid to all Shareholders whose names were on the register on 27 May 2022.

 

A second interim dividend of 6.00 pence per share in respect of the year ending 31 December 2022 was declared on 13 September 2022. This was paid on 7 November 2022 to those Shareholders on the Register of Members on 23 September 2022. Payment of this second interim dividend has reduced NAV per share (shown above) to 80.50 pence and increased cumulative dividends paid to 153.20 pence per share. 

 

DIVIDEND INVESTMENT SCHEME ("DIS")

 

On 8 July 2022, 586,156 shares were allotted through the DIS during the period at a price of 98.69 pence per share.

 

INVESTMENT ACTIVITY DURING THE PERIOD

 

New Investment during the period

On 9 September 2022, the Company completed a new investment of £0.50 million into Focalpoint Positioning Limited, a navigation and positioning technology company.

 

On 12 September 2022, a new investment of £0.44 million was made into Orri Limited, a provider of specialist eating disorder treatments.

 

Follow-on investments during the period

On 5 July 2022, a follow on investment of £0.62 million was made into Vivacity Labs Limited, an AI and urban traffic control business.

 

On 23 August 2022, a follow on investment of £0.33 million was made into Bleach London Holdings Limited, a hair colourants brand.

 

Loan repayments and other proceeds during the period

The Company received deferred consideration of £0.04 million from Media Business Insight Holdings Limited, an investment realised in a prior quarter.

 

Share buy-backs

On 23 September 2022, the Company purchased 332,076 of its own ordinary shares at a price of 80.43 pence per share.

 

All shares bought back by the Company were subsequently cancelled.

 

ACTIVITY AFTER THE PERIOD END

 

Loan Repayments and other proceeds

On 21 October 2022, a loan repayment (including premium) from Jablite Holdings Limited of £0.05 million was received.

 

Share buy-backs

On 7 October 2022, the Company purchased 338,012 of its own ordinary shares at a price of 80.43 pence per share.

 

All shares bought back by the Company were subsequently cancelled.

 

 

DIVIDEND INVESTMENT SCHEME ("DIS")

On 7 November 2022, 1,129,699 shares were allotted through the DIS at a price of 80.50 pence per share.

 

 

 

Please note that all of the above information is unaudited.

 

Other than as described above, there were no material events during the period and to the date of this announcement.

 

For further information, please contact:

Gresham House Asset Management Limited

Company Secretary: 020 7382 0999

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEZLFFLFLLFBK
Date   Source Headline
18th Feb 20159:05 amRNSIssue of Equity
6th Feb 201510:37 amRNSOffer Update
15th Jan 20153:50 pmRNSOffer Update
15th Jan 201512:59 pmRNSDirector/PDMR Shareholding
15th Jan 201512:56 pmRNSDirector/PDMR Shareholding
15th Jan 201512:55 pmRNSDirector/PDMR Shareholding
15th Jan 201512:47 pmRNSIssue of Equity
23rd Dec 201412:33 pmRNSOffer Update
19th Dec 20144:49 pmRNSIssue of Supplementary Prospectus
10th Dec 20145:36 pmRNSOffer for Subscription - Launch
14th Nov 20149:03 amRNSTransaction in Own Shares
11th Nov 20142:08 pmRNSInterim Management Statement
11th Nov 20149:18 amRNSTotal Voting Rights
22nd Oct 20143:05 pmRNSIntention to launch offers for subscription
22nd Oct 201412:00 pmRNSIntention to launch offers for subscription
2nd Oct 20149:12 amRNSTransaction in Own Shares
1st Oct 201412:23 pmRNSTotal Voting Rights
12th Sep 20144:05 pmRNSIssue of Equity
1st Sep 20144:42 pmRNSTotal Voting Rights
19th Aug 201410:46 amRNSNational Storage Mechanism
13th Aug 20144:25 pmRNSHalf Yearly Report
7th Jul 20149:29 amRNSDirector Declaration
25th Jun 20149:54 amRNSTransaction in Own Shares
6th Jun 20142:29 pmRNSIssue of Equity
2nd Jun 20149:39 amRNSOffer Update
2nd Jun 20149:37 amRNSOffer Update
2nd Jun 20149:33 amRNSOffer Update
19th May 20142:21 pmRNSIssue of Equity
16th May 20148:41 amRNSTransaction in Own Shares
14th May 20148:48 amRNSTransaction in Own Shares
12th May 20143:03 pmRNSInterim Management Statement
9th May 20146:01 pmRNSAGM Statement
29th Apr 20143:37 pmRNSOffer Update
16th Apr 20145:39 pmRNSOffer Update
7th Apr 20149:58 amRNSIssue of Equity
4th Apr 20149:19 amRNSIssue of Equity
1st Apr 201411:17 amPRNDirector/PDMR Shareholding
1st Apr 201411:13 amPRNIssue of Equity
26th Mar 201410:40 amPRNSupplementary Prospectus
25th Mar 20149:15 amPRNTransaction in Own Shares
24th Mar 20147:00 amPRNOffer Update
12th Feb 20143:41 pmPRNIssue of Equity
10th Jan 20147:00 amPRNDirector/PDMR Shareholding
9th Jan 20146:01 pmPRNIssue of Equity
19th Dec 20132:15 pmPRNIssue of Supplementary Prospectus
19th Dec 20132:14 pmPRNIssue of Supplementary Prospectus
19th Dec 20132:14 pmPRNIssue of Supplementary Prospectus
19th Dec 20132:13 pmPRNIssue of Supplementary Prospectus
3rd Dec 20139:32 amPRNTotal Voting Rights
29th Nov 20137:00 amPRNJoint Offer for Subscription and Issue of Prospectus

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.